Why getting an accurate lymphoma diagnosis matters
If you or a loved one has been diagnosed with lymphoma, you might think all you need to know is whether it’s Hodgkin or non-Hodgkin. But is that distinction enough to move forward confidently with a treatment plan? Or, is there more you should find out first?
Lymphoma specialists Sairah Ahmed, M.D., and Jason Westin, M.D., weighed in on this topic during a recent episode of UT MD Anderson...
Two-time tongue cancer survivor: Why I support research at UT MD Anderson
Sometimes, the most meaningful breakthroughs in medicine aren’t about saving your life — they’re about saving your quality of life. That was...
Stage 4 cervical cancer survivor thankful for immunotherapy clinical trial
Looking back, Paulette Burkhart believes the fatigue she began experiencing in 2023 was not because she needed to take vitamins or get more...
Understanding adenoid cystic carcinoma: Symptoms, treatment and outlook
Adenoid cystic carcinoma is a rare cancer of the secretory glands, which are glandular tissues that make and release substances such as saliva, tears and sweat. It can develop throughout your body, but it is most common in the salivary glands in your head and neck.
Here, I’ll share more about adenoid cystic carcinoma, including symptoms, prognosis and the research we’re doing to advance treatment.
How rare is adenoid cystic...
Astrocytoma survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson
Until Groundhog Day 2018, I’d been living a healthy and normal life in Austin with my wife, Amy, and our two young children. Then one day,...
Total neoadjuvant therapy: A new era for patients with locally advanced rectal cancer
When rectal cancer advances to involve nearby lymph nodes but hasn’t spread to other areas of the body, it’s considered to be locally advanced...
7 ways to support UT MD Anderson
If you’re eager to give back to UT MD Anderson — whether because the treatment you received here extended your life or those of the people...
‘Drug hunter’ deploys AI to accelerate path to new therapies
When Tim Heffernan, Ph.D., arrived at UT MD Anderson in 2011, he saw an opportunity to fundamentally change how cancer drugs are developed...
Understanding VEXAS Syndrome: Why this often-missed condition affects men over 50
VEXAS syndrome is a clonal blood disorder that can trigger widespread inflammation throughout the body and mostly affects men over age 50....
Leukemia survivor finds companionship of rescue dog during treatment
Mark Janes’ chronic lymphocytic leukemia (CLL) diagnosis came after he’d initially visited his doctor for swollen lymph nodes in his neck....